SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001564590-21-057142
Filing Date
2021-11-16
Accepted
2021-11-16 06:30:55
Documents
14
Period of Report
2021-11-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A txmd-8ka_20211111.htm   iXBRL 8-K/A 39124
2 EX-99.1 txmd-ex991_16.htm EX-99.1 82796
3 GRAPHIC g2qrvzx0ul1b000001.jpg GRAPHIC 4411
  Complete submission text file 0001564590-21-057142.txt   287588

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA txmd-20211111.xsd EX-101.SCH 5709
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20211111_lab.xml EX-101.LAB 20037
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20211111_pre.xml EX-101.PRE 11944
7 EXTRACTED XBRL INSTANCE DOCUMENT txmd-8ka_20211111_htm.xml XML 4190
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-00100 | Film No.: 211414056
SIC: 2834 Pharmaceutical Preparations